#CURECA
LightNews LightNews
360dx.bsky.social
www.360dx.com/molecular-di...
Seegene Previews Modular End-to-End PCR Automation System at ADLM
The South Korean firm said that its CURECA system offers walk-away PCR testing with 24/7 operation without human intervention after samples are loaded.
www.360dx.com
August 1, 2025 at 1:01 PM
sptimes.bsky.social
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July With a fully modular design, CURECATM introduces a bold vision for automating pre-treatment across diverse PCR specimen types Developed for future integration into unattended workflows ...
dlvr.it
May 2, 2025 at 2:17 PM
sptimes.bsky.social
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire PCR workforce, from sample pre-processing to result analysis.- Designed for 24-hour, seven-days-a-week, unattended, CURECA™ reflects the company's mission to set...
dlvr.it
April 9, 2025 at 2:17 PM
alyoumalsabea.com.web.brid.gy
شركة Seegene تؤسس فرعًا تابعًا لها في فرنسا لتوسيع حضورها في أوروبا
– فرنسا تصبح ثامن فرع مبيعات خارجي لـ Seegene وثالث فرع في أوروبا بعد إيطاليا وألمانيا – تُصنَّف فرنسا كثاني أكبر سوق للتشخيص الجزيئي في أوروبا، مدفوعةً بالطلب في مجالات العدوى المنقولة جنسيًا واختبارات الجهاز الهضمي، والكشف عن الفيروسات التنفسية. – من المتوقع أن يُسرّع الفرع الجديد من وتيرة اعتماد حلول Seegene قيد التطوير، ™CURECA [...] The post شركة Seegene تؤسس فرعًا تابعًا لها في فرنسا لتوسيع حضورها في أوروبا appeared first on اليوم السابع - Alyoum Alsabea.
alyoumalsabea.com
December 6, 2025 at 1:08 AM
laotiantimes.com.web.brid.gy
Seegene Establishes French Subsidiary to Expand European Footprint
– France becomes Seegene’s ninth overseas sales subsidiary and third in Europe, following Italy and Germany – The country ranks as Europe’s second-largest molecular diagnostics market, driven by demand in sexually transmitted infections and gastrointestinal testing, and respiratory virus detection. – The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, […]
laotiantimes.com
December 5, 2025 at 4:39 PM
aespicyx.bsky.social
e cureca pode?
September 6, 2024 at 6:41 PM
asianewstoday.bsky.social
Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025 #Featured #TechnologiesAndInnovation
Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data – STAgora™, the big data platform set to transform the future of diagnostics Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end SEOUL, South Korea , […] The post Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025 first appeared on Asia News Today.
dlvr.it
July 26, 2025 at 7:14 AM
asianewstoday.bsky.social
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation #Featured #TechnologiesAndInnovation
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July With a fully modular design, CURECATM introduces a bold vision for automating pre-treatment across diverse PCR specimen types Developed for future integration into unattended workflows and adaptable laboratory settings SEOUL, South Korea, May 5, 2025 /PRNewswire/ — […] The post Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation first appeared on Asia News Today.
dlvr.it
May 5, 2025 at 12:02 PM
asianewstoday.bsky.social
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation #Featured #TechnologiesAndInnovation
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July With a fully modular design, CURECATM introduces a bold vision for automating pre-treatment across diverse PCR specimen types Developed for future integration into unattended workflows and adaptable laboratory settings SEOUL, South Korea, May 2, 2025 /PRNewswire/ — […] The post Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation first appeared on Asia News Today.
dlvr.it
May 2, 2025 at 4:10 PM
magdalenadj.bsky.social
mmmmmm 😋 patka bi bila idealna. imali smo ćureća 😉 pire je fantazija sam po sebi
December 8, 2024 at 5:14 PM
epsteinweb.bsky.social
Parts 1-4/6 — EFTA01279094.jpg
#epsteinweb #efta01279094
https://epsteinweb.org
EFTA01279007 | EFTA01279094 Important information about your statement (Continued) Apemen, or ACCOLII Agreerrenl and the General Time ad Conditions U3S Statement of Credit Practices available in egmeemonts indeed:ewes at mar tin nwratery w,lw&w res. Yew assists Your stamens itemizes securities and other asset> hell I -. the accent at the end of to statement triad. You may ark for daserr d fait paid seosiies al anytime. You may receise securities iced as loin collateral alter paying any balance eta on them. Any securities translated to tie Firm clan; the itslemmt penod ale liked at market vane as of the end of the stational period. • Cost bald. detemning the cost basis of tie securities incbded in this statement, were indicated wits the number " l, • LBS F nonce& Services has relied al information obtained from wets other Wan t.85 Financial Senices, including information from another rem a that sum./ taste grovided to yea Finarial Adam The Firm does rot irdepercknely vereya gamma the aco_racy rally of ary information provided by was otter than LESFa-uncial Seneca h adhere although UPS Financel Services gamely le:dates fi b nformation as it is reserved, the him does not provide art, Amu:woes that the it-Mali:el Lahr 'Cost basis' and *Unrealized gar/loss- is accurate as of the date of tee statement. As wok please do not rays on this rdamdion to make perchne ix sale decisions fa taxi:crimes a otherwise. Accounts tundared to tie Fim may WW1gait loss llama:on only for the periodd tine they we held ache Fim More historical reformation can be aindby yea Friaxial Advisor. • Unrealised gansdoweas %teen data n awilabk, *sinew/ areasiced guinelown at cricsiaird Ice irentileal sec" lots. The trans/clan data for relvilial lots may or may not reflect commisans, anda security reads- taten events dentd and otier reinvestment lots ad systernatk pachasie lots are each combined todinky ale averaged lot. The 'Trade date' colann presents the original transaction trade date. • Callable securities Bonds and pretend stock that We issues cats for eat redenpan will be selected Pflennally by lot from wrap all scathes of that issue held ei our name cell nomhee rime for or clients. Call bare /Aureola) es obtained Isom third pain and Rs musky is not garanowd. Other tall foams may ant which own ailed wok( <made information alit* provided upon request • Certificates of deposit (ON). CDs are FDIC enured 'pito $29),000 ia principal and woad intend per depoUtor and per depository invasion in accordance was MK neon. • Pricavalus Prices Wel:mei for acuities and oter prodats may be higher or betel than the price that you would ectualY naive in the make hikes m obtained from wrion thid party sources which we tetra to be relable, but we donor storaitee tar accuracy. - We rim* use the donna price when ea/WA a Or mean of the bid and ask prices for hued swein and option; or only bid prices for OTC seare - Less actrreir traded securities may be priced using a valuation model ate moss recent prce eve dawned end may not reflect en actual markel price a vale - Certain posithns may apper *khan a price arid will thee a 'pike was nol sealable' it we we stable to obtain a pace fora sec ey - Deposita a securities denominated el CUITOWC91 ogler tun U.S dollres are reflected as the enchains. rate a of the statement date. - fcc chain narks adding n non-conformng denornnstions, puce and quantity (face nada) may have been adjusted to balks taper vitiation To obtain &mem guavas, when avaitabk, contact s , anal a.±,c<' • Private investments and otructaired peoduaa. nixes renew* saunas (ex LrIng erect participation program and catenate investment rut noshes) and structred products are whelk, highly diopid. Certain Waned prods% have not been regetered with the Securitees and E.dage Commasian a under any date sewiltieTaira. We investment crade nineties' values foe cecinas crd structured products for informatinal purposes cny. Marary base guaranteed. - These vibes may differ abstadishi km prices, il riy any, at which a pane hvestmerrl matured produa maybe bought or sold and don rot necesswiy represent the vain trou may receive sport licuidatian - Chid pry estmetes of vela are as a a certain date rd we suppled to UBS Fnaxii Services on a regaar basis by an independent saltation firm. - baser. go-wanpanne- or sponsor estimated vales. if any, are applied to the Fm by the issuer, general partner or mama and may be calculated based on deferent information frees tut used by third parties to dtrive their 'ginned values. - You can obtain addce-el information regarded the metcoblagy used to determine the estimate d value ad the dale of the recemasin Owe is the basis fa the ecimate by contaarg your Financial Advisor - Thirdparty 'singed sakes may be reflected as 'Not priced' in several SilUalbli: when an 1-dependent valuation lire has not sselaal a is stable to assign a saw. nailer. we become awn that a matenal ewnt has ocoared that may call a maws," reported vela Iwo question, or when a value would be highy nepenthe due to tie nature the waxily. - When neither n Esuer, general partner or wow Minted %clue nor a thrd-paly estimated net* is provided, the vale ol te mosey will bedRkrrn lean its pashas: price. - NT/61660;cent° daft' mayinclude ram of capita( income orboth. - 'Original unk size' represents the noel offering price per twit alS may not reflect your Cott bases - DIP add unlined RErt sautes are not irked co a national securities exchange, and se grin* liquid and own if they can be sod. to peke received may be less than the per tare estirruted wire provided n the a-cant statement • Restricted securints. Bearded secant generals, ae not :unsay etrable tor public sale. U8SFinarel Seances uses the mewl price d the unrestricted stock of the sane issuer as an inputed value for the restricted Pak laroorposts oiled statement osW To the extent tut restkled seorkies are elgble to sale, the vale received may be sdastarenaly less thanthe Swaged nuke frown • En. (scanned) income. anent yields and rates. M estimate of annual income is based on current dnidend ad interest rates, assuring rw seoakes will be held for one yea from statement date or seta maturity This Minn* no* a gudelne; accuracy ad continued income are not quadrant - Estimated arta hcane and curent yield for certain types of leashes could nckusle a return of cachet or capital gahs in which use the est income (and cureca yell would be overstated. - Estimated anal income and anent yield and the actual ?cane and yieU micfi be lower°, higher than the titillated aribeuntt. - An sestina* of wreaked income (dei:lend anacr interest) divided by the current mailer valaraverage balance is based on the Inv dividend or bleed payment made by tie issuer and manes tie sectreeddepaes will be held for ore year from Is statement date or until metres), Accuracy ad continued all we not wasaniewl • Assets not held by t185 Financial Services. Certain assets ere rot held by the Finn NW not %whin the Fern's posansen or ccntrol. These assets ere desplayed on yar statement for informational purposes only Positions and values presented as provided by dal Wing fern. UBS Inaba' ieraeces not renorable for this information and des not guarantee es mangy. Thew assets are not protected by SOK or the Fern's flipPlernereal9PC coverage. • Revenue sharing and sdisfitioned commands.. — In addition to carmissions on sin and UbiI lees received n carecticrt with tie daributiai mutual fund to ow dents we anchor our Wheat, receive revenue Thfling payments from diknbutors ado salsas of thenatal funds that we sell. These arnants are based on two oWerern components (k the emoted of YIN by UBS of a Patter mutual fund I amiY to our clients: and (m) the asset value of aparticular mutual fund fanny's shares held a the Wm — We and ow Aline ako receive networking and orrnbus crowning fees n consideration for transfer agent Seveei that ate provide to the mutual Knob. These fees generally are pad from investor
February 16, 2026 at 4:44 AM
antara-poster.bsky.social
Seegene Lansir CURECA™ dan STAgora™ di ADLM 2025, Mempercepat Babak Perkembangan Berikutnya dalam Industri Diagnostik - https://www.antaranews.com/berita/5023425/seegene-lansir-cureca-dan-stagora-di-adlm-2025-mempercepat-babak-perkembangan-berikutnya-dalam-industri-diagnostik
Seegene Lansir CURECA™ dan STAgora™ di ADLM 2025, Mempercepat Babak Perkembangan Berikutnya dalam Industri Diagnostik
Seegene Inc., pemimpin pasar diagnostik molekuler di dunia, melansir dua teknologi baru di ADLM 2025 yang berlangsung di Chicago (29-31 Juli). Kedua teknologi ...
www.antaranews.com
August 8, 2025 at 1:57 AM
antara-poster.bsky.social
Seegene Lansir Otomatisasi PCR Pertama di Dunia Tanpa Bantuan Manusia, Ubah Paradigma Industri Diagnostik Global di ADLM 2025 - https://www.antaranews.com/berita/4994485/seegene-lansir-otomatisasi-pcr-pertama-di-dunia-tanpa-bantuan-manusia-ubah-paradigma-industri-diagnostik-global-di-adlm-2025
Seegene Lansir Otomatisasi PCR Pertama di Dunia Tanpa Bantuan Manusia, Ubah Paradigma Industri Diagnostik Global di ADLM 2025
Seegene Inc., pemimpin pasar diagnostik molekuler di dunia, hari ini mengumumkan rencana untuk memperkenalkan sistem pemeriksaan PCR otomatis, CURECA&trade;, ...
www.antaranews.com
July 26, 2025 at 3:14 PM
antara-poster.bsky.social
Seegene CURECA(TM) Berpotensi Menjadi Terobosan Penting yang Mengotomatisasi Alur Kerja PCR secara Terpadu - https://www.antaranews.com/berita/4820829/seegene-curecatm-berpotensi-menjadi-terobosan-penting-yang-mengotomatisasi-alur-kerja-pcr-secara-terpadu
Seegene CURECA(TM) Berpotensi Menjadi Terobosan Penting yang Mengotomatisasi Alur Kerja PCR secara Terpadu
Seegene Inc., pemimpin pasar diagnostik molekuler (molecular diagnostics/MDx) di dunia, menarik perhatian luas setelah mempresentasikan video konseptual ...
www.antaranews.com
May 8, 2025 at 3:11 AM
antara-poster.bsky.social
Seegene Umumkan Pengembangan CURECA™, Solusi PCR Otomatis Generasi Baru Mengotomatisasi Tahap Persiapan Sampel - https://www.antaranews.com/berita/4774205/seegene-umumkan-pengembangan-cureca-solusi-pcr-otomatis-generasi-baru-mengotomatisasi-tahap-persiapan-sampel
Seegene Umumkan Pengembangan CURECA™, Solusi PCR Otomatis Generasi Baru Mengotomatisasi Tahap Persiapan Sampel
Seegene Inc., pemimpin pasar diagnostik molekuler (molecular diagnostics/MDx), mempercepat visinya untuk menghadirkan inovasi dalam otomatisasi laboratorium ...
www.antaranews.com
April 16, 2025 at 5:45 AM
newsen.bsky.social
Seegene Unveils Advanced STAgora Platform at ESCMID Global 2026 with Real-Time Data Insights#Seegene#CURECA#STAgora
Seegene Unveils Advanced STAgora Platform at ESCMID Global 2026 with Real-Time Data Insights
At ESCMID Global 2026, Seegene introduced STAgora, a platform enhancing real-time data analysis with automated PCR workflows, impressing healthcare professionals worldwide.
third-news.com
April 27, 2026 at 8:31 AM
newsen.bsky.social
Seegene Unveils STAgora at ESCMID Global 2026, Showcasing Real-Time Data Analysis#South_Korea#Seoul#Seegene#CURECA#STAgora
Seegene Unveils STAgora at ESCMID Global 2026, Showcasing Real-Time Data Analysis
Discover Seegene's innovative approach to integrating real-time data analysis with automated PCR workflows, introduced at ESCMID Global 2026.
third-news.com
April 27, 2026 at 7:25 AM
newsen.bsky.social
Seegene Unveils Revolutionary STAgora Real-Time Data Platform at ESCMID Global 2026#South_Korea#Seoul#Seegene#CURECA#STAgora
Seegene Unveils Revolutionary STAgora Real-Time Data Platform at ESCMID Global 2026
Seegene introduces STAgora, a pioneering real-time data platform enhancing PCR workflows, fostering global health insights at ESCMID Global 2026.
third-news.com
April 20, 2026 at 1:32 PM
newsen.bsky.social
Seegene Unveils STAgora: A Real-Time Data Analytics Solution at ESCMID Global 2026#Germany#Munich#Seegene#CURECA#STAgora
Seegene Unveils STAgora: A Real-Time Data Analytics Solution at ESCMID Global 2026
Seegene has introduced STAgora, a groundbreaking real-time data analytics platform that enhances automated PCR workflows, showcased at ESCMID 2026 in Munich.
third-news.com
April 20, 2026 at 1:30 PM
newsen.bsky.social
Seegene Expands Its Operations in Europe by Establishing a Subsidiary in France#Paris#France#Seegene#CURECA#STAgora
Seegene Expands Its Operations in Europe by Establishing a Subsidiary in France
Seegene Inc. has launched a new subsidiary in France, enhancing its presence in Europe, focusing on diagnostics and local partnerships.
third-news.com
December 5, 2025 at 8:11 AM
newsen.bsky.social
Seegene Expands Operations in Europe with New Subsidiary in France#South_Korea#Seoul#Seegene#CURECA#STAgora
Seegene Expands Operations in Europe with New Subsidiary in France
Seegene, a leader in molecular diagnostics, establishes a new subsidiary in France to enhance its presence in Europe and accelerate product adoption.
third-news.com
December 5, 2025 at 8:10 AM
newsen.bsky.social
Seegene Expands Its European Footprint with New Sales Branch in France#Paris#France#Seegene#CURECA#STAgora
Seegene Expands Its European Footprint with New Sales Branch in France
Seegene has announced the inauguration of a new sales branch in France, aiming to reinforce its presence in the European market and support global expansion.
third-news.com
December 5, 2025 at 8:09 AM
newsen.bsky.social
Seegene Expands European Presence with New Subsidiary in France#France#N/A#Molecular_Diagnostics#Seegene#CURECA
Seegene Expands European Presence with New Subsidiary in France
Seegene, a leader in molecular diagnostics, has announced the establishment of a new subsidiary in France to enhance its market presence and support healthcare partnerships.
third-news.com
December 5, 2025 at 8:09 AM
newsen.bsky.social
Seegene Expands European Presence with New French Subsidiary Launch#South_Korea#Seoul#Seegene#CURECA#STAgora
Seegene Expands European Presence with New French Subsidiary Launch
Seegene, a leader in molecular diagnostics, announced its new subsidiary in France, enhancing its European presence and market share.
third-news.com
December 5, 2025 at 6:08 AM
newsen.bsky.social
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Revolutionizing Diagnostics#USA#Chicago#Seegene#CURECA™#STAgora
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Revolutionizing Diagnostics
Seegene Inc. showcases its innovations, CURECA™ and STAgora™, at ADLM 2025, significantly enhancing diagnostic automation and disease monitoring.
third-news.com
August 13, 2025 at 7:00 AM